Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

BCS
Home/The Filing Wire/Assembly Biosciences, Inc./ 4

Changes in Beneficial Ownership · 4

Assembly Biosciences, Inc.

ASMBNASDAQEQUITYCurrent

Changes in Beneficial Ownership

Filed May 27, 2026Accepted May 27, 2026, 8:55 PM EDTCIK 1426800Accession 0001123292-26-000751
View company →Permanent SEC source ↗
Share

Company context

Assembly Biosciences is a biotechnology company dedicated to the development of innovative small-molecule therapeutics aimed at advancing the treatment paradigm of serious viral and liver diseases and improving the lives of patients worldwide. Led by an accomplished leadership team in antiviral and liver disease drug development, Assembly Bio is committed to improving outcomes for people living with the chronic impacts of herpesvirus, hepatitis delta virus (HDV) infections, cholestatic liver diseases and hepatitis B virus (HBV). For more information, visit assemblybio.com.

Current securities

ASMBNASDAQ · EQUITY · Current

Recent company filings

  1. S-8 filingAug 20, 2026
  2. 8-K/A filingAug 14, 2026
  3. 10-Q filingAug 13, 2026
  4. Completion of Acquisition or Disposition of AssetsAug 13, 2026
  5. SCHEDULE 13G/A filingAug 13, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.